Natural Investments LLC Buys 895 Shares of Church & Dwight Co., Inc. $CHD

Natural Investments LLC raised its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 47.2% during the 2nd quarter, Holdings Channel reports. The fund owned 2,791 shares of the company’s stock after acquiring an additional 895 shares during the period. Natural Investments LLC’s holdings in Church & Dwight were worth $268,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of CHD. Nuveen LLC bought a new position in Church & Dwight in the 1st quarter valued at about $106,736,000. Vanguard Group Inc. raised its holdings in Church & Dwight by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 31,441,639 shares of the company’s stock valued at $3,461,410,000 after acquiring an additional 750,575 shares during the period. American Century Companies Inc. increased its holdings in shares of Church & Dwight by 48.3% during the first quarter. American Century Companies Inc. now owns 2,115,040 shares of the company’s stock worth $232,845,000 after purchasing an additional 688,863 shares during the period. Vaughan Nelson Investment Management L.P. bought a new position in shares of Church & Dwight during the first quarter worth approximately $41,743,000. Finally, Jacobs Levy Equity Management Inc. bought a new position in shares of Church & Dwight during the first quarter worth approximately $35,521,000. 86.60% of the stock is owned by institutional investors.

Insider Buying and Selling at Church & Dwight

In related news, CEO Richard A. Dierker bought 5,470 shares of the business’s stock in a transaction on Tuesday, August 12th. The shares were purchased at an average price of $91.57 per share, for a total transaction of $500,887.90. Following the completion of the transaction, the chief executive officer directly owned 27,212 shares of the company’s stock, valued at approximately $2,491,802.84. This represents a 25.16% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Lee B. Mcchesney bought 5,409 shares of the business’s stock in a transaction on Friday, August 8th. The stock was bought at an average price of $91.38 per share, for a total transaction of $494,274.42. Following the transaction, the executive vice president directly owned 5,409 shares of the company’s stock, valued at approximately $494,274.42. This represents a ? increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 12,879 shares of company stock worth $1,177,702 over the last quarter. Corporate insiders own 2.00% of the company’s stock.

Church & Dwight Stock Performance

NYSE CHD opened at $87.61 on Friday. The company has a current ratio of 1.84, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $21.34 billion, a price-to-earnings ratio of 41.33, a P/E/G ratio of 3.65 and a beta of 0.43. The firm’s 50 day simple moving average is $91.38 and its 200 day simple moving average is $96.12. Church & Dwight Co., Inc. has a 1 year low of $85.08 and a 1 year high of $116.46.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.09. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.48 billion. Church & Dwight had a net margin of 8.66% and a return on equity of 19.27%. The firm’s revenue for the quarter was down .3% on a year-over-year basis. During the same quarter last year, the business posted $0.93 EPS. Church & Dwight has set its FY 2025 guidance at 3.440-3.510 EPS. Q3 2025 guidance at 0.720-0.720 EPS. As a group, research analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Friday, August 15th were given a $0.295 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.18 dividend on an annualized basis and a yield of 1.3%. Church & Dwight’s dividend payout ratio (DPR) is currently 55.66%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Church & Dwight in a report on Wednesday. Evercore ISI lowered their target price on shares of Church & Dwight from $102.00 to $101.00 and set an “in-line” rating on the stock in a report on Monday, August 4th. Barclays lowered their target price on shares of Church & Dwight from $84.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, August 4th. Rothschild & Co Redburn cut shares of Church & Dwight from a “neutral” rating to a “sell” rating and set a $83.00 target price on the stock. in a report on Monday, July 14th. Finally, Citigroup lowered their target price on shares of Church & Dwight from $88.00 to $85.00 and set a “sell” rating on the stock in a report on Thursday. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, Church & Dwight currently has an average rating of “Hold” and a consensus price target of $100.88.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.